Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Lab sells Jeedimetla API manufacturing business unit to Therapiva
>>
Dr. Reddy’s Lab soars on launching Colesevelam HCI Tablets
>>
Dr. Reddy’s Lab launches Colesevelam HCI Tablets
>>
Dr Reddy's recalls around 70,000 vials of Zoledronic acid injection from US
>>
Dr. Reddy's Lab’s arm sells rights of Cloderm Cream to EPI Health
>>
Dr. Reddy’s Lab sells its antibiotic manufacturing site, related assets in Bristol
>>
Dr. Reddy's Lab regains worldwide rights to DFA-02
>>
Dr Reddys Holdings submits disclosure
>>
Dr. Reddy's Lab shines on launching Neostigmine Methylsulfate Injection in US
>>
Dr. Reddy's Lab launches Neostigmine Methylsulfate Injection in US
<<
<
76
77
78
...145
>
>>